Treatment of Acute Respiratory Distress Syndrome in the Poisoned Patient

  • Dylan W. de Lange
Reference work entry


Lung-damaging toxicants may be defined as chemicals that induce pathological changes in the lung following absorption [1, 2]. The acute respiratory distress syndrome (ARDS) is a clinical syndrome which might be caused by direct damage to the respiratory cells at the alveolar level or indirectly through inflammation mediators in a severely exposed patient.



Parts of this chapter are based upon chapters written by Dorsett D. Smith and Jeffrey L. Burgess in previous editions of this book.


  1. 1.
    de Lange DW, Meulenbelt J. Do corticosteroids have a role in preventing or reducing acute toxic lung injury caused by inhalation of chemical agents? Clin Toxicol (Phila). 2011;49(2):61–71.CrossRefGoogle Scholar
  2. 2.
    de Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila). 2013;51(5):385–93.CrossRefGoogle Scholar
  3. 3.
    Varma DR, Guest I. The Bhopal accident and methyl isocyanate toxicity. J Toxicol Environ Health. 1993;40(4):513–29.PubMedCrossRefGoogle Scholar
  4. 4.
    Trumpener U. The road to ypres: the beginnings of gas warfare in world war I. J Mod Hist. 1975;47:460–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Sidell FR, Takafuji ET, Franz DR. Medical aspects of chemical and biological warfare. Washington, DC: Borden Institute, Walter Reed Army Medical Center; 1997.CrossRefGoogle Scholar
  6. 6.
    Szinicz L. History of chemical and biological warfare agents. Toxicology. 2005;214(3):167–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Emad A, Rezaian GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest. 1997;112(3):734–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Miller K, Chang A. Acute inhalation injury. Emerg Med Clin North Am. 2003;21(2):533–57.PubMedCrossRefGoogle Scholar
  9. 9.
    Sangster B, Meulenbelt J. Acute pulmonary intoxications. Overview and practical guidelines. Neth J Med. 1988;33(1–2):91–100.PubMedGoogle Scholar
  10. 10.
    Vanzetto G, Akret C, Bach V, Barone G, Durand M, Chavanon O, et al. Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single centre experience in 100 consecutive patients. Can J Cardiol. 2009;25(6):e179–86.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Tanen DA, Graeme KA, Raschke R. Severe lung injury after exposure to chloramine gas from household cleaners. N Engl J Med. 1999;341(11):848–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Pirjavec A, Kovic I, Lulic I, Zupan Z. Massive anhydrous ammonia injury leading to lung transplantation. J Trauma. 2009;67(4):E93–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Leduc D, Gris P, Lheureux P, Gevenois PA, De Vuyst P, Yernault JC. Acute and long term respiratory damage following inhalation of ammonia. Thorax. 1992;47(9):755–7.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Herbert FA, Orford R. Pulmonary hemorrhage and edema due to inhalation of resins containing tri-mellitic anhydride. Chest. 1979;76(5):546–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Cohen N, Modai D, Khahil A, Golik A. Acute resin phenol-formaldehyde intoxication. A life threatening occupational hazard. Hum Toxicol. 1989;8(3):247–50.PubMedCrossRefGoogle Scholar
  16. 16.
    Serinken M, Karcioglu O, Evyapan F, Sungurtekin H. Bilateral pneumothorax following acute inhalation injury. Clin Toxicol (Phila). 2009;47(6):595–7.CrossRefGoogle Scholar
  17. 17.
    Rabinovitch S, Greyson ND, Weiser W, Hoffstein V. Clinical and laboratory features of acute sulfur dioxide inhalation poisoning: two-year follow-up. Am Rev Respir Dis. 1989;139(2):556–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Bansal DP, Ambegaonkar R, Radhika P, Sharma M. ARDS following inhalation of hydrochloric acid. J Assoc Physicians India. 2011;59:115–7.PubMedGoogle Scholar
  19. 19.
    Tsonis L, Hantsch-Bardsley C, Gamelli RL. Hydrofluoric acid inhalation injury. J Burn Care Res. 2008;29(5):852–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Kono K, Watanabe T, Dote T, Usuda K, Nishiura H, Tagawa T, et al. Successful treatments of lung injury and skin burn due to hydrofluoric acid exposure. Int Arch Occup Environ Health. 2000;73(Suppl):S93–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Chela A, Reig R, Sanz P, Huguet E, Corbella J. Death due to hydrofluoric acid. Am J Forensic Med Pathol. 1989;10(1):47–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Mahmood T, Khasawneh KR, Halloush RA, Khasawneh FA. A 39-year-old male slaughterhouse worker with recurrent fever, cough, and shortness of breath. Chest. 2013;144(6):1959–63.PubMedCrossRefGoogle Scholar
  23. 23.
    Frierson WB. Use of pyridoxine HCl in acute hydrazine and UDMH intoxication. Ind Med Surg. 1965;34:650–1.PubMedGoogle Scholar
  24. 24.
    Pettilä V, Takkunen O, Tukiainen P. Zinc chloride smoke inhalation: a rare cause of severe acute respiratory distress syndrome. Intensive Care Med. 2000;26(2):215–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Hjortsø E, Ovist J, Bud MI, Thomsen JL, Andersen JB, Wiberg-Jørgensen F, et al. ARDS after accidental inhalation of zinc chloride smoke. Intensive Care Med. 1988;14(1):17–24.PubMedCrossRefGoogle Scholar
  26. 26.
    Kunimasa K, Arita M, Tachibana H, Tsubouchi K, Konishi S, Korogi Y, et al. Chemical pneumonitis and acute lung injury caused by inhalation of nickel fumes. Intern Med. 2011;50(18):2035–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Tanaka N, Emoto T, Matsumoto T, Matsunaga N, Tsuruta R, Lynch DA. Inhalational lung injury due to nitrogen dioxide: high-resolution computed tomography findings in 3 patients. J Comput Assist Tomogr. 2007;31(5):808–11.PubMedCrossRefGoogle Scholar
  28. 28.
    Ainslie G. Inhalational injuries produced by smoke and nitrogen dioxide. Respir Med. 1993;87(3):169–74.PubMedCrossRefGoogle Scholar
  29. 29.
    McKeown NJ, Burton BT. Acute lung injury following refrigeration coil deicing. Clin Toxicol (Phila). 2012;50(3):218–20.CrossRefGoogle Scholar
  30. 30.
    Lim S-C, Yang J-Y, Jang A-S, Park Y-U, Kim Y-C, Choi I-S, Park K-O. Acute lung injury after phosgene inhalation. Korean J Intern Med. 1996;11(1):87–92.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Lemoine TJ, Schoolman K, Jackman G, Vernon DD. Unintentional fatal phosphine gas poisoning of a family. Pediatr Emerg Care. 2011;27(9):869–71.PubMedCrossRefGoogle Scholar
  32. 32.
    Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis. 1993;148(5):1363–72.PubMedCrossRefGoogle Scholar
  33. 33.
    Samet JM, Hatch GE, Horstman D, Steck-Scott S, Arab L, Bromberg PA, et al. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med. 2001;164(5):819–25.PubMedCrossRefGoogle Scholar
  34. 34.
    Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest J. 2001;120(1):275–82.CrossRefGoogle Scholar
  35. 35.
    Greenspon AJ, Kidwell GA, Hurley W, Mannion J. Amiodarone-related postoperative adult respiratory distress syndrome. Circulation. 1991;84(5 Suppl):III407–15.PubMedGoogle Scholar
  36. 36.
    Chugh SN, Ram S, Mehta LK, Arora BB, Malhotra KC. Adult respiratory distress syndrome following aluminium phosphide ingestion. Report of 4 cases. J Assoc Physicians India. 1989;37(4):271–2.PubMedGoogle Scholar
  37. 37.
    Nemery B. Metal toxicity and the respiratory tract. Eur Respir J. 1990;3(2):202–19.PubMedGoogle Scholar
  38. 38.
    Guharoy SR. Adult respiratory distress syndrome associated with amitriptyline overdose. Vet Hum Toxicol. 1994;36(4):316–7.PubMedGoogle Scholar
  39. 39.
    Poe RH, Condemi JJ, Weinstein SS, Schuster RJ. Adult respiratory distress syndrome related to ampicillin sensitivity. CHEST J. 1980;77(3):449–51.CrossRefGoogle Scholar
  40. 40.
    Cohen DM, Norberto J, Cartabuke R, Ryu G. Severe anaphylactic reaction after primary exposure to aprotinin. Ann Thorac Surg. 1999;67(3):837–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Bolliger CT, Van Zijl P, Louw JA. Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning. Respiration. 1992;59(1):57–61.PubMedCrossRefGoogle Scholar
  42. 42.
    Lai MW, Boyer EW, Kleinman ME, Rodig NM, Ewald MB. Acute arsenic poisoning in two siblings. Pediatrics. 2005;116(1):249–57.PubMedCrossRefGoogle Scholar
  43. 43.
    Suarez M, Krieger BP. Bronchoalveolar lavage in recurrent aspirin-induced adult respiratory distress syndrome. Chest J. 1986;90(3):452–3.CrossRefGoogle Scholar
  44. 44.
    Niehoff JM, Baltatzis PA. Adult respiratory distress syndrome induced by salicylate toxicity. Postgrad Med. 1985;78(1):117–9. 123.PubMedCrossRefGoogle Scholar
  45. 45.
    Luis M, Ayuso A, Martinez G, Souto M, Ortells J. Intraoperative respiratory failure in a patient after treatment with bleomycin: previous and current intraoperative exposure to 50% oxygen. Eur J Anaesthesiol. 1999;16(01):66–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Baban NK, Nunley DL, Borges Jr AS, Roy TM. Human sequelae of severe carbamate poisoning. Tenn Med. 1998;91(3):103–6.PubMedGoogle Scholar
  47. 47.
    Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol. 2001;13(4):242–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Mégarbane B, Chevillard L. The large spectrum of pulmonary complications following illicit drug use: features and mechanisms. Chem Biol Interact. 2013;206(3):444–51.PubMedCrossRefGoogle Scholar
  49. 49.
    Powell-Jackson PR, Carmichael FJL, Calne RY, Williams R. Adult respiratory distress syndrome and convulsions associated with administration of cyclosporine in liver transplant recipients. Transplantation. 1984;38(4):341–2.PubMedCrossRefGoogle Scholar
  50. 50.
    Tenenbein M, Kowalski S, Sienko A, Bowden DH, Adamson IYR. Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning. Lancet. 1992;339(8795):699–701.PubMedCrossRefGoogle Scholar
  51. 51.
    Mapp CE, Pozzato V, Pavoni V, Gritti G. Severe asthma and ARDS triggered by acute short-term exposure to commonly used cleaning detergents. Eur Respir J. 2000;16(3):570–2.PubMedCrossRefGoogle Scholar
  52. 52.
    Gossman DE, Schneider F. Hapten resistant dextran induced ARDS reaction following intracoronary stent deployment. Cathet Cardiovasc Diagn. 1996;38(1):56–61.PubMedCrossRefGoogle Scholar
  53. 53.
    Taylor MA, Diblasi SL, Bender RM, Santoian EC, Cha SD, Dennis CA. Adult respiratory distress syndrome complicating intravenous infusion of low-molecular weight dextran. Cathet Cardiovasc Diagn. 1994;32(3):249–53.PubMedCrossRefGoogle Scholar
  54. 54.
    Hernandez AF, Martin-Rubi JC, Ballesteros JL, Oliver M, Pla A, Villanueva E. Clinical and pathological findings in fatal 1,3-dichloropropene intoxication. Hum Exp Toxicol. 1994;13(5):303–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Lindsay CA, Williams GD, Levin DL. Fatal adult respiratory distress syndrome after diphenhydramine toxicity in a child: a case report. Crit Care Med. 1995;23(4):777–81.PubMedCrossRefGoogle Scholar
  56. 56.
    Serebruany VL, Sibbing D, DiNicolantonio JJ. Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond. Cardiology. 2014;127(1):20–4.PubMedCrossRefGoogle Scholar
  57. 57.
    Burton WN, Vender J, Shapiro BA. Adult respiratory distress syndrome after placidyl abuse. Crit Care Med. 1980;8(1):48–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Catchings TT, Beamer WC, Lundy L, Prough DS. Adult respiratory distress syndrome secondary to ethylene glycol ingestion. Ann Emerg Med. 1985;14(6):594–6.PubMedCrossRefGoogle Scholar
  59. 59.
    Piagnerelli M, Carlier E, Lejeune P. Adult respiratory distress syndrome and medullary toxicity: Two unusual complications of ethylene glycol intoxication. Intensive Care Med 1999;25(10):1200.PubMedCrossRefGoogle Scholar
  60. 60.
    Bracco D, Favre JB. Pulmonary injury after ski wax inhalation exposure. Ann Emerg Med. 1998;32(5):616–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Linskens RK, Golding RP, van Groeningen CJ, Giaccone G. Severe acute lung injury induced by gemcitabine. Neth J Med. 2000;56(6):232–5.PubMedCrossRefGoogle Scholar
  62. 62.
    Marruchella A, Fiorenzano G, Merizzi A, Rossi G, Chiodera PL. Diffuse alveolar damage in a patient treated with gemcitabine. Eur Respir J. 1998;11(2):504–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Byers JM, Soin JS, Fisher RS, Hutchins GM. Acute pulmonary alveolitis in narcotics abuse. Arch Pathol. 1975;99(5):273–7.PubMedGoogle Scholar
  64. 64.
    Thornton WE, Thornton BP. Adverse reactions to heroin use. South Med J. 1974;67(6):707–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Le HT, Bosse GM, Tsai Y. Ibuprofen overdose complicated by renal failure, adult respiratory distress syndrome, and metabolic acidosis. J Toxicol Clin Toxicol. 1994;32(3):315–20.PubMedCrossRefGoogle Scholar
  66. 66.
    Marciniak KE, Thomas IH, Brogan TV, Roberts JS, Czaja A, Mazor SS. Massive ibuprofen overdose requiring extracorporeal membrane oxygenation for cardiovascular support. Pediatr Crit Care Med. 2007;8(2):180–2.PubMedCrossRefGoogle Scholar
  67. 67.
    Scalzo AJ, Weber TR, Jaeger RW, Connors RH, Thompson MW. Extracorporeal membrane oxygenation for hydrocarbon aspiration. Am J Dis Child. 1990;144(8):867–71.PubMedGoogle Scholar
  68. 68.
    Weber TR, Tracy TF, Connors R, Kountzman B, Pennington DG. Prolonged extracorporeal support for nonneonatal respiratory failure. J Pediatr Surg. 1992;27(8):1100–4. discussion 1104–5.PubMedCrossRefGoogle Scholar
  69. 69.
    Möller JC, Vardag AM, Jonas S, Tegtmeyer FK. Poisoning with volatile hydrocarbons. 3 cases and a review. Monatsschr Kinderheilkd. 1992;140(2):113–6.PubMedGoogle Scholar
  70. 70.
    Bysani GK, Rucoba RJ, Noah ZL. Treatment of hydrocarbon pneumonitis. High frequency jet ventilation as an alternative to extracorporeal membrane oxygenation. Chest. 1994;106(1):300–3.PubMedCrossRefGoogle Scholar
  71. 71.
    Chyka PA. Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. J Toxicol Clin Toxicol. 1996;34(4):357–63.PubMedCrossRefGoogle Scholar
  72. 72.
    Mazzeo PA, Renny M, Osterhoudt KC. A toddler with curiosity and a cough. Pediatr Emerg Care. 2010;26(3):232–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Bille AB, Pedersen KD, Hertel S. Extracorporeal membrane oxygenation of a child with severe chemical pneumonia. Ugeskr Laeger. 2011;173(48):3115–6.PubMedGoogle Scholar
  74. 74.
    Bennion JR, Franzblau A. Chemical pneumonitis following household exposure to hydrofluoric acid. Am J Ind Med. 1997;31(4):474–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Garrettson LK, McGee EB. Rapid onset of seizures following aspiration of viscous lidocaine. J Toxicol Clin Toxicol. 1992;30(3):413–22.PubMedCrossRefGoogle Scholar
  76. 76.
    Promisloff RA, Dupont DC. Death from ARDS and cardiovascular collapse following lidocaine administration. Chest J. 1983;83(3):585a-585.CrossRefGoogle Scholar
  77. 77.
    Woelke BJ, Tucker RA. ARDS after local lidocaine administration. Chest J. 1983;83(6):933b–4.CrossRefGoogle Scholar
  78. 78.
    Howard JJ, Mohsenifar Z, Simons SM. Adult respiratory distress syndrome following administration of lidocaine. Chest J. 1982;81(5):644–5.CrossRefGoogle Scholar
  79. 79.
    Kansagra AJ, Yang E, Nambiar S, Patel PS, Karetzky MS. A rare case of acute respiratory distress syndrome secondary to acute lithium intoxication. Am J Ther. 2014;21(2):e31–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Friedman BC, Bekes CE, Scott WE, Bartter T. ARDS following acute lithium carbonate intoxication. Intensive Care Med. 1992;18(2):123–4.PubMedCrossRefGoogle Scholar
  81. 81.
    Aghabiklooei A, Shadnia S, Hassanian-Moghaddam H, Zamani N. Acute respiratory distress syndrome caused by methadone syrup. Arch Ind Hyg Toxicol. 2013;64(3):439–43.Google Scholar
  82. 82.
    Martin M. Methadone abuse noncardiogenic pulmonary oedema with adult. Reactions. 2011;1365:20.Google Scholar
  83. 83.
    Filgrastim/methotrexate. React Wkly. 2013;1435(1):13.Google Scholar
  84. 84.
    Finkelstein Y, Zevin S, Heyd J, Bentur Y, Zigelman Y, Hersch M. Emergency treatment of life-threatening intrathecal methotrexate overdose. Neurotoxicology. 2004;25(3):407–10.PubMedCrossRefGoogle Scholar
  85. 85.
    Dai MS, Ho CL, Chen YC, Kao WY, Chao TY. Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature. Ann Hematol. 2000;79(12):696–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Walubo A, Seger D. Fatal multi-organ failure after suicidal overdose with MDMA, ecstasy’: case report and review of the literature. Hum Exp Toxicol. 1999;18(2):119–25.PubMedGoogle Scholar
  87. 87.
    Lim HE, Shim JJ, Lee SY, Lee SH, Kang SY, Jo JY, et al. Mercury inhalation poisoning and acute lung injury. Korean J Intern Med. 1998;13(2):127–30.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Rendall RE, Phillips JI, Renton KA. Death following exposure to fine particulate nickel from a metal arc process. Ann Occup Hyg. 1994;38(6):921–30.PubMedGoogle Scholar
  89. 89.
    Wahba SS. Nitrofurantoin-induced acute respiratory distress syndrome during pregnancy: a case report. Egypt J Anaesthesia. 2014;30(1):101–2.CrossRefGoogle Scholar
  90. 90.
    Seidenschwanz IB, Breier-Wolski C, Flehmig J, Lison A, Muehlbauer B. Nitrofurantoin-induced pulmonary fibrosis resulting in death due to acute respiratory distress syndrome (ARDS). Naunyn Schmiedebergs Arch Pharmacol. 2007;375:110.Google Scholar
  91. 91.
    Mulberg AE, Bell LM. Fatal cholestatic hepatitis and multisystem failure associated with nitrofurantoin. J Pediatr Gastroenterol Nutr. 1993;17(3):307–9.PubMedCrossRefGoogle Scholar
  92. 92.
    Yockey CC, Eden BM, Byrd RB. The mcconnell missile accident. Clinical spectrum of nitrogen dioxide exposure. JAMA. 1980;244(11):1221–3.PubMedCrossRefGoogle Scholar
  93. 93.
    Cole JB, Dunbar JF, McIntire SA, Regelmann WE, Slusher TM. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage. Pediatrics. 2015;135(3):e740–3.PubMedCrossRefGoogle Scholar
  94. 94.
    Goetz AM, Rogers PL, Schlichtig R, Muder RR, Diven WF, Prior RB. Adult respiratory distress syndrome associated with epidural fentanyl infusion. Crit Care Med. 1994;22(10):1579–83.PubMedCrossRefGoogle Scholar
  95. 95.
    Kass R, Kochar G, Lippman M. Adult respiratory distress syndrome from organophosphate poisoning. Am J Emerg Med. 1991;9(1):32–3.PubMedCrossRefGoogle Scholar
  96. 96.
    Kamijo Y, Soma K, Uchimiya H, Asari Y, Ohwada T. A case of serious organophosphate poisoning treated by percutaneous cardiopulmonary support. Vet Hum Toxicol. 1999;41(5):326–8.PubMedGoogle Scholar
  97. 97.
    Kamholz S, Veith FJ, Mollenkopf F, Montefusco C, Nehlsen-Cannarella S, Kaleya R, et al. Single lung transplantation in paraquat intoxication. N Y State J Med. 1984;84(2):82–4.PubMedGoogle Scholar
  98. 98.
    The Toronto Lung Transplant Group. Sequential bilateral lung transplantation for paraquat poisoning. A case report. J Thorac Cardiovasc Surg. 1985;89:734–42.Google Scholar
  99. 99.
    Walder B, Bründler MA, Spiliopoulos A, Romand JA. Successful single-lung transplantation after paraquat intoxication. Transplantation. 1997;64(5):789–91.PubMedCrossRefGoogle Scholar
  100. 100.
    Licker M, Schweizer A, Hohn L, Morel DR, Spiliopoulos A. Single lung transplantation for adult respiratory distress syndrome after paraquat poisoning. Thorax. 1998;53(7):620–1.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Chen JG, Eldridge DL, Lodeserto FJ, Ming DY, Turner KM, Vanderford JL, et al. Paraquat ingestion: a challenging diagnosis. Pediatrics. 2010;125(6):e1505–9.PubMedCrossRefGoogle Scholar
  102. 102.
    Eshel G, Usher M, Barr J, Heggesh R, Lahat E. Phenothiazine treatment and respiratory distress syndrome in a child. J Toxicol Clin Toxicol. 1994;32(2):191–7.PubMedCrossRefGoogle Scholar
  103. 103.
    Mecca P, Tobin E, Andrew Carlson J. Photo-distributed neutrophilic drug eruption and adult respiratory distress syndrome associated with antidepressant therapy. J Cutan Pathol. 2004;31(2):189–94.PubMedCrossRefGoogle Scholar
  104. 104.
    Batchelor N, Holley A. A fatal case of propylthiouracil-induced anca-positive vasculitis. MedGenMed. 2006;8(4):10.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Nguyen MD, Hoang LT, Luong MD, FACP, Quoc KV, Pham MD, Vu B. An antineutrophil cytoplasmic autoantibody associated with a propylthiouracil-induced adult respiratory distress-like syndrome: report of a case and review of the literature. Endocr Pract. 1998;4(2):89–93.Google Scholar
  106. 106.
    Chevrolet JC, Guelpa G, Schifferli JA. Recurrent adult respiratory distress-like syndrome associated with propylthiouracil therapy. Eur Respir J. 1991;4(7):899–901.PubMedGoogle Scholar
  107. 107.
    Borak J, Diller WF. Phosgene exposure: mechanisms of injury and treatment strategies. J Occup Environ Med. 2001;43(2):110–9.PubMedCrossRefGoogle Scholar
  108. 108.
    Urdaneta F, Lobato EB, Kirby RR, Horrow JC. Noncardiogenic pulmonary edema associated with protamine administration during coronary artery bypass graft surgery. J Clin Anesth. 1999;11(8):675–81.PubMedCrossRefGoogle Scholar
  109. 109.
    Gupta SK, Veith FJ, Ascer E, Wengerter KR, Franco C, Amar D, et al. Anaphylactoid reactions to protamine: an often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery. J Vasc Surg. 1989;9(2):342–50.PubMedCrossRefGoogle Scholar
  110. 110.
    Rahman M, Hashmey R, Abuhasna S. Quinine-induced bronchiolitis obliterans and organizing pneumonia. J Anaesthesiol Clin Pharmacol. 2012;28(4):505.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Wenstone R, Bell M, Mostafa S. Fatal adult respiratory distress syndrome after quinine overdose. Lancet. 1989;333(8647):1143–4.CrossRefGoogle Scholar
  112. 112.
    Machiels JP, Evrard P, Dive A, Bulpa P, Installé E. Venovenous ECMO in life-threatening radiocontrast mediated-ards. Intensive Care Med. 1999;25(5):546.PubMedCrossRefGoogle Scholar
  113. 113.
    Esteban A, Guerra L, Ruiz-Santana S, Fernandez A, Fernandez-Segoviano P. ARDS due to ingestion of denatured rapeseed oil. Chest. 1983;84(2):166–9.PubMedGoogle Scholar
  114. 114.
    Pentel P, Fletcher D, Jentzen J. Fatal acute selenium toxicity. J Forensic Sci. 1985;30(2):556–62.PubMedCrossRefGoogle Scholar
  115. 115.
    Okumura T, Suzuki K, Kumada K, Kobayashi R, Fukuda A, Fujii C, Kohama A. Severe respiratory distress following sodium oleate ingestion. J Toxicol Clin Toxicol. 1998;36(6):587–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Tio R, Voorbij RH, Enthoven R. Adult respiratory distress syndrome after streptokinase. Am J Cardiol. 1992;70(20):1632–3.PubMedCrossRefGoogle Scholar
  117. 117.
    Martin TR, Sandblom RL, Johnson RJ. Adult respiratory distress syndrome following thrombolytic therapy for pulmonary embolism. Chest. 1983;83(1):151–3.PubMedCrossRefGoogle Scholar
  118. 118.
    Knapp MJ, Bunn WB, Stave GM. Adult respiratory distress syndrome from sulfuric acid fume inhalation. South Med J. 1991;84(8):1031–3.PubMedCrossRefGoogle Scholar
  119. 119.
    Whitmore TJ, O’Shea JP, Starac D, Edwards MG, Waterer GW. A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy. Chest. 2014;145(3):639–41.PubMedCrossRefGoogle Scholar
  120. 120.
    Gruson D, Hubert G, Portel L, Gbikpi-Benissan G, Cardinaud JP, Boiron JM, et al. Acute respiratory distress syndrome due to all-trans retinoic acid. Intensive Care Med. 1998;24(6):642.PubMedCrossRefGoogle Scholar
  121. 121.
    Zuckerman GB, Conway EE. Pulmonary complications following tricyclic antidepressant overdose in an adolescent. Ann Pharmacother. 1993;27(5):572–4.PubMedCrossRefGoogle Scholar
  122. 122.
    Varnell RM, Godwin JD, Richardson ML, Vincent JM. Adult respiratory distress syndrome from overdose of tricyclic antidepressants. Radiology. 1989;170(3 Pt 1):667–70.PubMedCrossRefGoogle Scholar
  123. 123.
    Lyle WH, Payton JE, Hui M. Haemodialysis and copper fever. Lancet. 1976;1(7973):1324–5.PubMedCrossRefGoogle Scholar
  124. 124.
    Chian CF, Wu CP, Chen CW, Su WL, Yeh CB, Perng WC. Acute respiratory distress syndrome after zinc chloride inhalation: survival after extracorporeal life support and corticosteroid treatment. Am J Crit Care. 2010;19(1):86–90.PubMedCrossRefGoogle Scholar
  125. 125.
    Lee K, Hung D. Zotepine-Induced acute respiratory distress syndrome (abstract 22). Abstracts of the 2010 international congress of the european association of poisons centres and clinical toxicologists, 11–14 may 2010, bordeaux, france. Clin Toxicol (Phila). 2010;48(3):240–318.CrossRefGoogle Scholar
  126. 126.
    Xu L, Xu J, Wang Z. Molecular mechanisms of paraquat-induced acute lung injury: a current review. Drug Chem Toxicol. 2014;37(2):130–4.PubMedCrossRefGoogle Scholar
  127. 127.
    Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334–49.PubMedCrossRefGoogle Scholar
  128. 128.
    Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to escherichia coli endotoxin. J Clin Invest. 1991;88(3):864–75.PubMedPubMedCentralCrossRefGoogle Scholar
  129. 129.
    Modelska K, Pittet JF, Folkesson HG, Courtney Broaddus V, Matthay MA. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1450–6.PubMedCrossRefGoogle Scholar
  130. 130.
    Bitterman PB. Pathogenesis of fibrosis in acute lung injury. Am J Med. 1992;92(6A):39S–43.PubMedCrossRefGoogle Scholar
  131. 131.
    Aggarwal NR, King LS, D’Alessio FR. Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol. 2014;306(8):L709–25.PubMedPubMedCentralCrossRefGoogle Scholar
  132. 132.
    Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. J Immunol. 2015;194(3):855–60.PubMedPubMedCentralCrossRefGoogle Scholar
  133. 133.
    Doi K, Ishizu T, Fujita T, Noiri E. Lung injury following acute kidney injury: kidney-lung crosstalk. Clin Exp Nephrol. 2011;15(4):464–70.PubMedCrossRefGoogle Scholar
  134. 134.
    Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest. 2009;136(6):1631–43.PubMedCrossRefGoogle Scholar
  135. 135.
    Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to drosophila toll. Proc Natl Acad Sci U S A. 1998;95(2):588–93.PubMedPubMedCentralCrossRefGoogle Scholar
  136. 136.
    Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11(5):373–84.PubMedCrossRefGoogle Scholar
  137. 137.
    Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat Med. 2005;11(11):1173–9.PubMedCrossRefGoogle Scholar
  138. 138.
    Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS. Distinct roles of pattern recognition receptors CD14 and toll-like receptor 4 in acute lung injury. Infect Immun. 2005;73(3):1754–63.PubMedPubMedCentralCrossRefGoogle Scholar
  139. 139.
    Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, McIntyre RC. Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol. 2004;287(3):R592–9.PubMedCrossRefGoogle Scholar
  140. 140.
    Franchi L, Muñoz-Planillo R, Núñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 2012;13(4):325–32.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Fredenburgh L, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med. 2012;185(11):1225–34.PubMedPubMedCentralCrossRefGoogle Scholar
  142. 142.
    Hauser CJ, Sursal T, Rodriguez EK, Appleton PT, Zhang Q, Itagaki K. Mitochondrial damage associated molecular patterns from femoral reamings activate neutrophils through formyl peptide receptors and P44/42 MAP kinase. J Orthop Trauma. 2010;24(9):534–8.PubMedPubMedCentralCrossRefGoogle Scholar
  143. 143.
    Lee YL, King MB, Gonzalez RP, Brevard SB, Frotan MA, Gillespie MN, Simmons JD. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. J Surg Res. 2014;191(2):286–9.PubMedPubMedCentralCrossRefGoogle Scholar
  144. 144.
    Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, et al. Mitochondrial damps increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One. 2013;8(3):e59989.PubMedPubMedCentralCrossRefGoogle Scholar
  145. 145.
    Vadász I, Weiss CH, Sznajder JI. Ubiquitination and proteolysis in acute lung injury. Chest. 2012;141(3):763–71.PubMedPubMedCentralCrossRefGoogle Scholar
  146. 146.
    Yamada T, Uehara K, Kawanishi R, Mizutani T, Sunagawa K, Araya J, Kawabata Y. Immunohistochemical detection of ubiquitin-positive intracytoplasmic eosinophilic inclusion bodies in diffuse alveolar damage. Histopathology. 2006;48(7):846–54.PubMedCrossRefGoogle Scholar
  147. 147.
    Thomas GM, Carbo C, Curtis BR, Martinod K, Mazo IB, Schatzberg D, et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood. 2012;119(26):6335–43.PubMedPubMedCentralCrossRefGoogle Scholar
  148. 148.
    Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med. 1997;155(4):1187–205.PubMedCrossRefGoogle Scholar
  149. 149.
    Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med. 1997;3(3):320–3.PubMedCrossRefGoogle Scholar
  150. 150.
    Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2(7511):319–23.PubMedCrossRefGoogle Scholar
  151. 151.
    Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720–3.PubMedCrossRefGoogle Scholar
  152. 152.
    Villar J, Sulemanji D, Kacmarek RM. The acute respiratory distress syndrome: incidence and mortality, has it changed? Curr Opin Crit Care. 2014;20(1):3–9.PubMedCrossRefGoogle Scholar
  153. 153.
    Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573–82.PubMedCrossRefGoogle Scholar
  154. 154.
    Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the berlin definition. JAMA. 2012;307(23):2526–33.PubMedGoogle Scholar
  155. 155.
    Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, et al. Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med. 2009;179(3):220–7.PubMedCrossRefGoogle Scholar
  156. 156.
    Dushianthan A, Grocott MP, Postle AD, Cusack R. Acute respiratory distress syndrome and acute lung injury. Postgrad Med J. 2011;87(1031):612–22.PubMedCrossRefGoogle Scholar
  157. 157.
    Suchyta MR, Clemmer TP, Elliott CG, Orme JF, Weaver LK. The adult respiratory distress syndrome. A report of survival and modifying factors. Chest. 1992;101(4):1074–9.PubMedCrossRefGoogle Scholar
  158. 158.
    Mégarbane B, Leprince P, Deye N, Résière D, Guerrier G, Rettab S, et al. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med. 2007;33(5):758–64.PubMedCrossRefGoogle Scholar
  159. 159.
    Masson R, Colas V, Parienti JJ, Lehoux P, Massetti M, Charbonneau P, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012;83:1413.PubMedCrossRefGoogle Scholar
  160. 160.
    Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338(6):347–54.PubMedCrossRefGoogle Scholar
  161. 161.
    Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and volume-limited ventilation strategy group. N Engl J Med. 1998;338(6):355–61.PubMedCrossRefGoogle Scholar
  162. 162.
    Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondéjar E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The multicenter trail group on tidal volume reduction in ARDS. Am J Respir Crit Care Med. 1998;158(6):1831–8.PubMedCrossRefGoogle Scholar
  163. 163.
    Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P, Wiener CM, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med. 1999;27(8):1492–8.PubMedCrossRefGoogle Scholar
  164. 164.
    The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–8.Google Scholar
  165. 165.
    Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327–36.PubMedCrossRefGoogle Scholar
  166. 166.
    Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):646–55.PubMedCrossRefGoogle Scholar
  167. 167.
    Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):637–45.PubMedCrossRefGoogle Scholar
  168. 168.
    Talmor D, Sarge T, Malhotra A, O’Donnell CR, Ritz R, Lisbon A, et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008;359(20):2095–104.PubMedPubMedCentralCrossRefGoogle Scholar
  169. 169.
    Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–68.PubMedCrossRefGoogle Scholar
  170. 170.
    Gattinoni L, Caironi P, Pelosi P, Goodman LR. What has computed tomography taught us about the acute respiratory distress syndrome? Am J Respir Crit Care Med. 2001;164(9):1701–11.PubMedCrossRefGoogle Scholar
  171. 171.
    Slutsky AS. Lung injury caused by mechanical ventilation. Chest. 1999;116(1 Suppl):9S–15.PubMedCrossRefGoogle Scholar
  172. 172.
    Boussarsar M, Thierry G, Jaber S, Roudot-Thoraval F, Lemaire F, Brochard L. Relationship between ventilatory settings and barotrauma in the acute respiratory distress syndrome. Intensive Care Med. 2002;28(4):406–13.PubMedCrossRefGoogle Scholar
  173. 173.
    Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126–36.PubMedCrossRefGoogle Scholar
  174. 174.
    Villar J, Kacmarek RM, Pérez-Méndez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med. 2006;34(5):1311–8.PubMedCrossRefGoogle Scholar
  175. 175.
    Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747–55.PubMedCrossRefGoogle Scholar
  176. 176.
    Ochiai R. Mechanical ventilation of acute respiratory distress syndrome. J Intensive Care. 2015;3(1):25.PubMedPubMedCentralCrossRefGoogle Scholar
  177. 177.
    de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, et al. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156.PubMedPubMedCentralCrossRefGoogle Scholar
  178. 178.
    Eastwood G, Bellomo R, Bailey M, Taori G, Pilcher D, Young P, Beasley R. Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med. 2012;38(1):91–8.PubMedCrossRefGoogle Scholar
  179. 179.
    Damiani E, Adrario E, Girardis M, Romano R, Pelaia P, Singer M, Donati A. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. 2014;18(6):711.PubMedPubMedCentralCrossRefGoogle Scholar
  180. 180.
    Hernandez ML, Harris B, Lay JC, Bromberg PA, Diaz-Sanchez D, Devlin RB, et al. Comparative airway inflammatory response of normal volunteers to ozone and lipopolysaccharide challenge. Inhal Toxicol. 2010;22(8):648–56.PubMedPubMedCentralCrossRefGoogle Scholar
  181. 181.
    Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007;175(2):160–6.PubMedCrossRefGoogle Scholar
  182. 182.
    Petersson J, Rohdin M, Sánchez-Crespo A, Nyrén S, Jacobsson H, Larsson SA, et al. Paradoxical redistribution of pulmonary blood flow in prone and supine humans exposed to hypergravity. J Appl Physiol. 2006;100(1):240–8.PubMedCrossRefGoogle Scholar
  183. 183.
    Hu SL, He HL, Pan C, Liu AR, Liu SQ, Liu L, et al. The effect of prone positioning on mortality in patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. Crit Care. 2014;18(3):R109.PubMedPubMedCentralCrossRefGoogle Scholar
  184. 184.
    Pelosi P, Rocco PR, de Abreu MG. Use of computed tomography scanning to guide lung recruitment and adjust positive-end expiratory pressure. Curr Opin Crit Care. 2011;17(3):268–74.PubMedCrossRefGoogle Scholar
  185. 185.
    Henzler D, Mahnken AH, Wildberger JE, Rossaint R, Günther RW, Kuhlen R. Multislice spiral computed tomography to determine the effects of a recruitment maneuver in experimental lung injury. Eur Radiol. 2006;16(6):1351–9.PubMedCrossRefGoogle Scholar
  186. 186.
    Costa EL, Borges JB, Melo A, Suarez-Sipmann F, Toufen C, Bohm SH, Amato MB. Bedside estimation of recruitable alveolar collapse and hyperdistension by electrical impedance tomography. Intensive Care Med. 2009;35(6):1132–7.PubMedCrossRefGoogle Scholar
  187. 187.
    Muders T, Luepschen H, Zinserling J, Greschus S, Fimmers R, Guenther U, et al. Tidal recruitment assessed by electrical impedance tomography and computed tomography in a porcine model of lung injury. Crit Care Med. 2012;40(3):903–11.PubMedCrossRefGoogle Scholar
  188. 188.
    Blankman P, Hasan D, Erik G, Gommers D. Detection of ‘best’ positive end-expiratory pressure derived from electrical impedance tomography parameters during a decremental positive end-expiratory pressure trial. Crit Care. 2014;18(3):R95.PubMedPubMedCentralCrossRefGoogle Scholar
  189. 189.
    Suter PM. Lung inflammation in ards – friend or foe? N Engl J Med. 2006;354(16):1739–42.PubMedCrossRefGoogle Scholar
  190. 190.
    Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711–23.PubMedCrossRefGoogle Scholar
  191. 191.
    Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J. 2006;27(2):413–26.PubMedCrossRefGoogle Scholar
  192. 192.
    Toward TJ, Broadley KJ. Airway function, oedema, cell infiltration and nitric oxide generation in conscious ozone-exposed guinea-pigs: effects of dexamethasone and rolipram. Br J Pharmacol. 2002;136(5):735–45.PubMedPubMedCentralCrossRefGoogle Scholar
  193. 193.
    Smith A, Brown R, Jugg B, Platt J, Mann T, Masey C, et al. The effect of steroid treatment with inhaled budesonide or intravenous methylprednisolone on phosgene-induced acute lung injury in a porcine model. Mil Med. 2009;174(12):1287–94.PubMedCrossRefGoogle Scholar
  194. 194.
    Liu F, Pauluhn J, Trübel H, Wang C. Single high-dose dexamethasone and sodium salicylate failed to attenuate phosgene-induced acute lung injury in rats. Toxicology. 2014;315:17–23.PubMedCrossRefGoogle Scholar
  195. 195.
    Kehrer JP, Klein-Szanto AJ, Sorensen EM, Pearlman R, Rosner MH. Enhanced acute lung damage following corticosteroid treatment. Am Rev Respir Dis. 1984;130(2):256–61.PubMedGoogle Scholar
  196. 196.
    Smith LJ, Brody JS. Influence of methylprednisolone on mouse alveolar type 2 cell response to acute lung injury. Am Rev Respir Dis. 1981;123(4 Pt 1):459–64.PubMedGoogle Scholar
  197. 197.
    Nightingale JA, Rogers DF, Chung KF, Barnes PJ. No effect of inhaled budesonide on the response to inhaled ozone in normal subjects. Am J Respir Crit Care Med. 2000;161(2 Pt 1):479–86.PubMedCrossRefGoogle Scholar
  198. 198.
    Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, et al. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. Environ Health Perspect. 2008;116(6):799–805.PubMedPubMedCentralCrossRefGoogle Scholar
  199. 199.
    Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009;37(5):1594–603.PubMedCrossRefGoogle Scholar
  200. 200.
    Meduri GU, Marik PE, Chrousos GP, Pastores SM, Arlt W, Beishuizen A, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med. 2008;34(1):61–9.PubMedCrossRefGoogle Scholar
  201. 201.
    Agarwal R, Nath A, Aggarwal AN, Gupta D. Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis. Respirology. 2007;12(4):585–90.PubMedCrossRefGoogle Scholar
  202. 202.
    Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ. 2008;336(7651):1006–9.PubMedPubMedCentralCrossRefGoogle Scholar
  203. 203.
    Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107–16.PubMedCrossRefGoogle Scholar
  204. 204.
    Alhazzani W, Alshahrani M, Jaeschke R, Forel JM, Papazian L, Sevransky J, Meade MO. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2013;17(2):R43.PubMedPubMedCentralCrossRefGoogle Scholar
  205. 205.
    Jackson JC, Girard TD, Gordon SM, Thompson JL, Shintani AK, Thomason JW, et al. Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med. 2010;182(2):183–91.PubMedPubMedCentralCrossRefGoogle Scholar
  206. 206.
    Burry L, Rose L, McCullagh IJ, Fergusson DA, Ferguson ND, Mehta S. Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation. Cochrane Database Syst Rev. 2014;7:CD009176.Google Scholar
  207. 207.
    Magazine R, Rao S, Chogtu B. Prescribing patterns of drugs in acute respiratory distress syndrome (ARDS): an observational study. J Clin Diagn Res. 2015;9(2):FC01–4.PubMedPubMedCentralGoogle Scholar
  208. 208.
    Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. Am J Respir Crit Care Med. 1997;156(4 Pt 1):1092–8.PubMedCrossRefGoogle Scholar
  209. 209.
    Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stéphan F, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132(8):621–30.PubMedCrossRefGoogle Scholar
  210. 210.
    Hill JD, O’Brien TG, Murray JJ, Dontigny L, Bramson ML, Osborn JJ, Gerbode F. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the bramson membrane lung. N Engl J Med. 1972;286(12):629–34.PubMedCrossRefGoogle Scholar
  211. 211.
    The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888–95.CrossRefGoogle Scholar
  212. 212.
    Tiruvoipati R, Botha J, Peek G. Effectiveness of extracorporeal membrane oxygenation when conventional ventilation fails: valuable option or vague remedy? J Crit Care. 2012;27(2):192–8.PubMedCrossRefGoogle Scholar
  213. 213.
    Combes A, Bacchetta M, Brodie D, Müller T, Pellegrino V. Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care. 2012;18(1):99–104.PubMedCrossRefGoogle Scholar
  214. 214.
    MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. 2012;38(2):210–20.PubMedCrossRefGoogle Scholar
  215. 215.
    Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365(20):1905–14.PubMedCrossRefGoogle Scholar
  216. 216.
    Terragni P, Faggiano C, Ranieri VM. Extracorporeal membrane oxygenation in adult patients with acute respiratory distress syndrome. Curr Opin Crit Care. 2014;20(1):86–91.PubMedCrossRefGoogle Scholar
  217. 217.
    Foley PJ, Morris RJ, Woo EY, Acker MA, Wang GJ, Fairman RM, Jackson BM. Limb ischemia during femoral cannulation for cardiopulmonary support. J Vasc Surg. 2010;52(4):850–3.PubMedCrossRefGoogle Scholar
  218. 218.
    Buscher H, Nair P. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2012;366(6):575; author reply 576.PubMedCrossRefGoogle Scholar
  219. 219.
    Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–63.PubMedCrossRefGoogle Scholar
  220. 220.
    Lee SH, Chung CH, Won Lee J, Ho Jung S, Choo SJ. Factors predicting early- and long-term survival in patients undergoing extracorporeal membrane oxygenation (ECMO). J Card Surg. 2012;27(2):255–63.PubMedCrossRefGoogle Scholar
  221. 221.
    Lindén V, Palmér K, Reinhard J, Westman R, Ehrén H, Granholm T, Frenckner B. Inter-hospital transportation of patients with severe acute respiratory failure on extracorporeal membrane oxygenation – national and international experience. Intensive Care Med. 2001;27(10):1643–8.PubMedCrossRefGoogle Scholar
  222. 222.
    Peek GJ, Elbourne D, Mugford M, Tiruvoipati R, Wilson A, Allen E, et al. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technol Assess. 2010;14(35):1–46.PubMedCrossRefGoogle Scholar
  223. 223.
    Moreno SG, Novielli N, Cooper NJ. Cost-effectiveness of the implantable heartmate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant. 2012;31(5):450–8.PubMedCrossRefGoogle Scholar
  224. 224.
    Feingold B, Arora G, Webber SA, Smith KJ. Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy. J Card Fail. 2010;16(9):734–41.PubMedPubMedCentralCrossRefGoogle Scholar
  225. 225.
    Harris A, Cooper BA, Li JJ, Bulfone L, Branley P, Collins JF, et al. Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis. 2011;57(5):707–15.PubMedCrossRefGoogle Scholar
  226. 226.
    St-Onge M, Fan E, Mégarbane B, Hancock-Howard R, Coyte PC. Venoarterial extracorporeal membrane oxygenation for patients in shock or cardiac arrest secondary to cardiotoxicant poisoning: a cost-effectiveness analysis. J Crit Care. 2015;30(2):437.e7-14.PubMedCrossRefGoogle Scholar
  227. 227.
    Harvey MJ, Gaies MG, Prosser LA. US and international in-hospital costs of extracorporeal membrane oxygenation: a systematic review. Appl Health Econ Health Policy. 2015;13:341.PubMedCrossRefGoogle Scholar
  228. 228.
    Azoulay E, Adrie C, De Lassence A, Pochard F, Moreau D, Thiery G, et al. Determinants of postintensive care unit mortality: a prospective multicenter study. Crit Care Med. 2003;31(2):428–32.PubMedCrossRefGoogle Scholar
  229. 229.
    Brinkman S, de Jonge E, Abu-Hanna A, Arbous MS, de Lange DW, de Keizer NF. Mortality after hospital discharge in ICU patients. Crit Care Med. 2013;41(5):1229–36.PubMedCrossRefGoogle Scholar
  230. 230.
    Brinkman S, De Jonge E, Abu-Hanna A, De Lange DW, De Keizer NF. The use of linked registries to assess long-term mortality of ICU patients. Stud Health Technol Inform. 2012;180:230–4.PubMedGoogle Scholar
  231. 231.
    Brandenburg R, Brinkman S, de Keizer NF, Meulenbelt J, de Lange DW. In-hospital mortality and long-term survival of patients with acute intoxication admitted to the ICU. Crit Care Med. 2014;42(6):1471–9.PubMedCrossRefGoogle Scholar
  232. 232.
    Brandenburg R, Brinkman S, de Keizer NF, Meulenbelt J, de Lange DW. The authors reply. Crit Care Med. 2015;43(1):e26.PubMedCrossRefGoogle Scholar
  233. 233.
    Wang CY, Calfee CS, Paul DW, Janz DR, May AK, Zhuo H, et al. One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensive Care Med. 2014;40(3):388–96.PubMedPubMedCentralCrossRefGoogle Scholar
  234. 234.
    Schmickl CN, Biehl M, Wilson GA, Gajic O. Comparison of hospital mortality and long-term survival in patients with acute lung injury/ARDS vs cardiogenic pulmonary edema. Chest. 2015;147(3):618–25.PubMedCrossRefGoogle Scholar
  235. 235.
    Soliman IW, de Lange DW, Peelen LM, Cremer OL, Slooter AJ, Pasma W, et al. Single-center large-cohort study into quality of life in dutch intensive care unit subgroups, 1 year after admission, using euroqol EQ-6D-3L. J Crit Care. 2015;30(1):181–6.PubMedCrossRefGoogle Scholar
  236. 236.
    Brandenburg R, Soliman IW, Meulenbelt J, de Lange DW. Raising awareness for a low health-related quality of life in intoxicated ICU patients. Clin Toxicol (Phila). 2015;53(6):585.CrossRefGoogle Scholar
  237. 237.
    Bienvenu OJ, Gellar J, Althouse BM, Colantuoni E, Sricharoenchai T, Mendez-Tellez PA, et al. Post-traumatic stress disorder symptoms after acute lung injury: a 2-year prospective longitudinal study. Psychol Med. 2013;43(12):2657–71.PubMedCrossRefGoogle Scholar
  238. 238.
    Wolters AE, van Dijk D, Pasma W, Cremer OL, Looije MF, de Lange DW, et al. Long-term outcome of delirium during intensive care unit stay in survivors of critical illness: a prospective cohort study. Crit Care. 2014;18(3):R125.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Intensive Care Medicine and the Dutch National Poison Information Center(NPIC) of the University Medical Center, University UtrechtUtrechtThe Netherlands

Personalised recommendations